+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Misoprostol compared with prostaglandin E2 for labour induction in women at term with intact membranes and unfavourable cervix: a systematic review



Misoprostol compared with prostaglandin E2 for labour induction in women at term with intact membranes and unfavourable cervix: a systematic review



Bjog 113(12): 1366-1376



Misoprostol is a commonly used prostaglandin to induce labour. A potential risk of induction, however, is caesarean delivery, especially in women with an unfavourable cervix. To evaluate the use of misoprostol, compared with prostaglandin E2 (PgE2), for labour induction in women at term with an unfavourable cervix and intact membranes. PubMed, Medline, EMBASE and the Cochrane Library were searched for articles published in any language from January 1987 to December 2005, using the keywords 'misoprostol', 'labour/labor' and 'induction'. We identified randomised trials of women at term (> or =37 weeks of gestation) with intact membranes and unfavourable cervix, undergoing labour induction with misoprostol, orally, vaginally, sublingually or buccally, compared with PgE2 vaginally or intracervically. Caesarean delivery was the primary outcome, with tachysystole and hyperstimulation as secondary outcomes. The primary analysis compared any misoprostol with any PgE2 for all women, with a subgroup analysis for nulliparous women. Secondary analyses compared different routes and doses of misoprostol (oral or vaginal and 25 microgram or >25 microgram) and PgE2 (intracervical or vaginal). Relative risks (RR) and 95% confidence intervals (CI) were calculated using random effects models. Main results Fourteen of 611 articles identified met the criteria for systematic review, with three providing information for nulliparous women. There was no difference in the risk of caesarean delivery between misoprostol and PgE2 groups (RR = 0.99, 95% CI = 0.83-1.17). Any misoprostol was associated with higher risks of tachysystole and hyperstimulation compared with any PgE2 (RR = 1.86, 95% CI = 1.01-3.43 and RR = 3.71, 95% CI = 2.00-6.88, respectively). There was a higher rate of vaginal delivery within 24 hours among all vaginal deliveries with any misoprostol compared with any PgE2 (RR = 1.14, 95% CI = 1.00-1.31), and among all deliveries, a lower rate of oxytocin use (RR = 0.71, 95% CI = 0.60-0.85) but a trend towards increased meconium staining was observed (RR = 1.22, 95% CI = 0.96-1.55). The use of misoprostol at starting dosages >25 microgram had similar findings to the primary analysis. Studies of lower misoprostol dosing (starting dose of 25 microgram) did not show any differences in the outcomes of interest, but the sample size of this secondary analysis was small (304 women, 155 receiving misoprostol). Although misoprostol in women at term with an unfavourable cervix and intact membranes was more effective than PgE2 in achieving vaginal delivery within 24 hours, misoprostol does not reduce the rate of caesarean delivery either in all women or in the subgroup of nulliparous women, and it increases the rates of tachysystole and hyperstimulation. Further studies of misoprostol using a starting dose of 25 microgram may be warranted.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049598878

Download citation: RISBibTeXText

PMID: 17081181

DOI: 10.1111/j.1471-0528.2006.01111.x


Related references

Sublingual misoprostol compared to artificial rupture of membranes plus oxytocin infusion for labour induction in nulliparous women with a favourable cervix of term. Hong Kong Medical Journal 12(5): 345-350, 2006

The routine use of oxytocin after oral misoprostol for labour induction in women with an unfavourable cervix is not of benefit. Australian and new Zealand Journal of Obstetrics and Gynaecology 46(4): 323-329, 2006

Preparation for induction of labour of the unfavourable cervix with Foley catheter compared with vaginal prostaglandin. Australian and new Zealand Journal of Obstetrics and Gynaecology 26(1): 30-35, 1986

Induction of labour in primigravid women with an unfavourable cervix A prospective comparative study of prostaglandin E-2 vaginal tablets and gel. Journal of Obstetrics & Gynaecology 13(2): 112-113, 1993

The use of vaginal prostaglandin E 2 tablets to induce labour in primiparae with an unfavourable cervix following spontaneous rupture of the membranes at or near term-a pilot study. Journal of Obstetrics & Gynaecology 9(3): 193-195, 1989

Effectiveness and safety of vaginal misoprostol for induction of labour in unfavourable cervix in 3rd trimester. Journal of Ayub Medical College Abbottabad 20(3): 33-35, 2009

Does induction of labour increase the risk of caesarean section? A systematic review and meta-analysis of trials in women with intact membranes. Bjog 121(6): 674-85; Discussion 685, 2014

Effectiveness and Safety of 2-Hourly 20 Mcg Oral Misoprostol Solution Compared to Standard Intravenous Oxytocin in Labour Induction Due to Pre-Labour Rupture of Membranes at Term: a Randomised Clinical Trial at Kenyatta National Hospital. East African Medical Journal 91(9): 303-310, 2014

Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes. Bjog 107(2): 222-227, 2000

Prospective randomised controlled trial to compare safety and efficacy of intravaginal Misoprostol with intracervical Cerviprime for induction of labour with unfavourable cervix. Journal of Obstetrics and Gynaecology 28(3): 294-297, 2008

Intracervical prostaglandin E-2, 0.5 mg; gel or tablet for cervical ripening and induction of labour with an unfavourable cervix?. Journal of Obstetrics & Gynaecology 13(3): 167-170, 1993

Cervical ripening before induction of labour in patients with an unfavourable cervix: a comparative randomized study of the Atad Ripener Device, prostaglandin E2 vaginal pessary, and prostaglandin E2 intracervical gel. Australian and new Zealand Journal of Obstetrics and Gynaecology 36(3): 291-295, 1996

Induction of labor with oral misoprostol for premature rupture of membranes at term in women with unfavorable cervix. Journal of Perinatal Medicine 35(4): 353-4; Author Reply 354, 2007

Comparative study of oestradiol and prostaglandin E2 vaginal gel for ripening the unfavourable cervix before induction of labour. British Medical Journal 282(6265): 679-681, 1981

Induction of labour in nulliparous women with an unfavourable cervix. Bjog 117(7): 892; Author Reply 892, 2010